Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Aromasin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5,616Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Marksans Pharma's UK Arm, Relonchem, Secures MHRA Approval
    Marksans Pharma's UK Arm, Relonchem, Secures MHRA Approval

    06 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/marksans-pharmas-uk-arm-relonchem-secures-mhra-nod-for-exemestane-25mg-tablets-18159

    INDPHARMAPOST
    06 Nov 2025
    Share Share
    Coral Drugs Receives CEP Approval for Exemestane!
    Coral Drugs Receives CEP Approval for Exemestane!

    22 Jul 2025

    // PRESS RELEASE

    https://www.coraldrugs.com/news/coral-drugs-receives-cep-approval-for-exemestane

    PRESS RELEASE
    22 Jul 2025
    Share Share
    We’re proud to announce our DMF (Drug Master File) approval
    We’re proud to announce our DMF (Drug Master File) approval

    14 May 2025

    // PRESS RELEASE

    https://www.coraldrugs.com/news/announce-drug-master-file-approval

    PRESS RELEASE
    14 May 2025
    Share Share
    Qilu Pharm`s Generic Exemestane Receives Approval in US
    Qilu Pharm`s Generic Exemestane Receives Approval in US

    16 Apr 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213547

    FDA
    16 Apr 2020
    Share Share
    Mayne Pharma’s Generic Exemestane Receives Approval In US
    Mayne Pharma’s Generic Exemestane Receives Approval In US

    13 Aug 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208764

    FDA
    13 Aug 2019
    Share Share
    Amneal Pharms' Generic Exemestane Receives Approval in US
    Amneal Pharms' Generic Exemestane Receives Approval in US

    31 Dec 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206421

    FDA
    31 Dec 2018
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.